Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thalidomide”

379 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 379 results

Testing effectiveness (Phase 2)Study completedNCT00025467
What this trial is testing

Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer

Who this might be right for
Endometrial AdenoacanthomaEndometrial AdenocarcinomaEndometrial Adenosquamous Cell Carcinoma+3 more
National Cancer Institute (NCI) 60
Large-scale testing (Phase 3)Study completedNCT02203253
What this trial is testing

Efficacy of Thalidomide in Preventing Chemotherapy-induced Delayed Nausea and Vomiting

Who this might be right for
Neoplasms
China Medical University, China 642
Testing effectiveness (Phase 2)UnknownNCT00384800
What this trial is testing

A Phase II Study of Tegafur/Uracil (UFUR®)Plus Thalidomide for the Treatment of Advanced or Metastatic Hepatocellular Carcinoma (HCC)

Who this might be right for
Carcinoma, Hepatocellular
Far Eastern Memorial Hospital 41
Testing effectiveness (Phase 2)Study completedNCT00201357
What this trial is testing

An Open Trial to Assess the Efficacy and Safety of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer

Who this might be right for
Hormone-refractory Prostate Cancer
National Health Research Institutes, Taiwan 30
Testing effectiveness (Phase 2)Study completedNCT00053430
What this trial is testing

Using the Drug Thalidomide to Stimulate T Cells in HIV-Infected People

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 40
Post-approval studies (Phase 4)UnknownNCT03777930
What this trial is testing

The Evaluation of Curative Effect on Treatment of Tumor Above Thalidomide Combined With Megestrol

Who this might be right for
Cancer, Therapy-Related
Shenzhen Fifth People's Hospital 200
Testing effectiveness (Phase 2)WithdrawnNCT03608501
What this trial is testing

Ixazomib, Thalidomide and Dexamethasone in Newly Diagnosed and Treatment-naive Multiple Myeloma (MM) Participants Non-eligible for Autologous Stem-cell Transplantation

Who this might be right for
Multiple Myeloma
Takeda
Testing effectiveness (Phase 2)UnknownNCT00378755
What this trial is testing

Sequential VAD and VTD Followed by HDT With ASCT and Velcade Maintenance for NDMM

Who this might be right for
Multiple Myeloma
Korean Multiple Myeloma Working Party 62
Large-scale testing (Phase 3)Ended earlyNCT00529633
What this trial is testing

The Effect of Thalidomide in Suppression of the Systemic Inflammatory Response Syndrome in Hemodialysis Patients

Who this might be right for
Hypoalbuminemia
George A. Kaysen, M.D. 16
Large-scale testing (Phase 3)Study completedNCT00111748
What this trial is testing

UARK 2005-01 Study of Velcade, Thalidomide, and Dexamethasone (VTD) With or Without Adriamycin® in Relapsed/Refractory Patients

Who this might be right for
Multiple Myeloma
University of Arkansas 180
Early research (Phase 1)Study completedNCT00000812
What this trial is testing

A Phase I, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Thalidomide in Subjects With HIV-1 Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Testing effectiveness (Phase 2)Study completedNCT00016224
What this trial is testing

Thalidomide in Treating Patients With Refractory or Resistant Epithelial Ovarian Cancer

Who this might be right for
Ovarian Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00054158
What this trial is testing

Combination Chemotherapy and Thalidomide in Treating Patients With Stage I, Stage II, or Stage III Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Roswell Park Cancer Institute 24
Testing effectiveness (Phase 2)UnknownNCT03062800
What this trial is testing

Study of Thalidomide in Treatment of Advanced Nsclc (Dream-003)

Who this might be right for
Advanced Nsclc
Qilu Hospital of Shandong University 232
Testing effectiveness (Phase 2)Ended earlyNCT00450008
What this trial is testing

Safety and Efficacy Study of GM-CSF, Thalidomide Plus Docetaxel in Prostate Cancer

Who this might be right for
Prostatic Neoplasms
The Methodist Hospital Research Institute 9
Large-scale testing (Phase 3)Ended earlyNCT00215943
What this trial is testing

Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD)

Who this might be right for
Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute 90
Testing effectiveness (Phase 2)Study completedNCT00001680
What this trial is testing

A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus Erythematosus

Who this might be right for
Discoid Lupus Erythematosus
National Cancer Institute (NCI) 17
Large-scale testing (Phase 3)Study completedNCT02707484
What this trial is testing

The Efficiency of Thalidomide for Recurrent Small Intestinal Bleeding Due to Gastrointestinal Vascular Malformation

Who this might be right for
Gastrointestinal Vascular Malformation
Shanghai Jiao Tong University School of Medicine 150
Not applicableUnknownNCT03601871
What this trial is testing

The Efficacy and Safety of Thalidomide in Preventing CINV Induced by Cisplatin-containing Chemotherapy

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Yunpeng Liu 880
Testing effectiveness (Phase 2)Study completedNCT00357500
What this trial is testing

Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer

Who this might be right for
Central Nervous System Tumor, PediatricLeukemiaLymphoma+3 more
Dana-Farber Cancer Institute 101
Load More Results